COPENHAGEN (Thomson Financial) - Danish pharmaceutical company Lundbeck AS is expected today to report a third-quarter pretax profit of 916 mln dkr, up 45 pct from a year earlier, according to a survey of analysts by RB Boersen.
From: www.sharewatch.com
OUTLOOK Lundbeck Q3 pretax seen rising; group expected to retain FY guidance
Posted by Ruslan Abuzant at 9:04 PM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment